Patient Profile 2: R/R Follicular Lymphoma with Early Disease Progression

Opinion
Video

Panelists review the previously presented patient case and discuss alternative treatment strategies in early disease progression with expert insight on preferred treatment approaches for this setting.

Recent Videos
Jose Sandoval Sus, MD, discussed standard CAR T-cell therapies in patients across multiple high-risk lymphoma indications.
4 experts in this video
4 experts in this video
Barriers to access and financial toxicities are challenges that must be addressed for CAR T-cell therapies in LBCL, according to Jose Sandoval Sus, MD.
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Related Content